S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in
ASX:PIQ

Proteomics International Laboratories Limited (PIQ.AX) Competitors

Add
Compare
Today's Range N/A
50-Day Range
A$0.36
MA: A$0.36
A$0.36
52-Week Range N/A
Volume126,546 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Proteomics International Laboratories Limited (PIQ.AX) (ASX:PIQ) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying PIQ stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Proteomics International Laboratories Limited (PIQ.AX), including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

(CHV) (CNSX:CHV) and Proteomics International Laboratories Limited (PIQ.AX) (ASX:PIQ) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (CHV) and Proteomics International Laboratories Limited (PIQ.AX), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Proteomics International Laboratories Limited (PIQ.AX)0000N/A

Profitability

This table compares (CHV) and Proteomics International Laboratories Limited (PIQ.AX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)N/AN/AN/A

Earnings & Valuation

This table compares (CHV) and Proteomics International Laboratories Limited (PIQ.AX)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)$2.73 million0.00$-2,098,120.00A($0.02)N/A

(CHV) has higher earnings, but lower revenue than Proteomics International Laboratories Limited (PIQ.AX).

Summary

Proteomics International Laboratories Limited (PIQ.AX) beats (CHV) on 1 of the 1 factors compared between the two stocks.

(DDXS) (OTCMKTS:DDXS) and Proteomics International Laboratories Limited (PIQ.AX) (ASX:PIQ) are both health technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (DDXS) and Proteomics International Laboratories Limited (PIQ.AX), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Proteomics International Laboratories Limited (PIQ.AX)0000N/A

Profitability

This table compares (DDXS) and Proteomics International Laboratories Limited (PIQ.AX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)N/AN/AN/A

Earnings & Valuation

This table compares (DDXS) and Proteomics International Laboratories Limited (PIQ.AX)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)$2.73 million0.00$-2,098,120.00A($0.02)N/A

(DDXS) has higher earnings, but lower revenue than Proteomics International Laboratories Limited (PIQ.AX).

Summary

Proteomics International Laboratories Limited (PIQ.AX) beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Proteomics International Laboratories Limited (PIQ.AX) (ASX:PIQ) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations for (PREV) and Proteomics International Laboratories Limited (PIQ.AX), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Proteomics International Laboratories Limited (PIQ.AX)0000N/A

Profitability

This table compares (PREV) and Proteomics International Laboratories Limited (PIQ.AX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)N/AN/AN/A

Earnings and Valuation

This table compares (PREV) and Proteomics International Laboratories Limited (PIQ.AX)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)$2.73 million0.00$-2,098,120.00A($0.02)N/A

(PREV) has higher earnings, but lower revenue than Proteomics International Laboratories Limited (PIQ.AX).

Summary

Proteomics International Laboratories Limited (PIQ.AX) beats (PREV) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and Proteomics International Laboratories Limited (PIQ.AX) (ASX:PIQ) are both health technology companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.

Earnings and Valuation

This table compares (TNGN) and Proteomics International Laboratories Limited (PIQ.AX)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)$2.73 million0.00$-2,098,120.00A($0.02)N/A

(TNGN) has higher earnings, but lower revenue than Proteomics International Laboratories Limited (PIQ.AX).

Profitability

This table compares (TNGN) and Proteomics International Laboratories Limited (PIQ.AX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for (TNGN) and Proteomics International Laboratories Limited (PIQ.AX), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
Proteomics International Laboratories Limited (PIQ.AX)0000N/A

Summary

Proteomics International Laboratories Limited (PIQ.AX) beats (TNGN) on 1 of the 1 factors compared between the two stocks.

138267 (COM.TO) (TSE:COM) and Proteomics International Laboratories Limited (PIQ.AX) (ASX:PIQ) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Earnings & Valuation

This table compares 138267 (COM.TO) and Proteomics International Laboratories Limited (PIQ.AX)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)$2.73 million0.00$-2,098,120.00A($0.02)N/A

138267 (COM.TO) has higher earnings, but lower revenue than Proteomics International Laboratories Limited (PIQ.AX).

Profitability

This table compares 138267 (COM.TO) and Proteomics International Laboratories Limited (PIQ.AX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
Proteomics International Laboratories Limited (PIQ.AX)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for 138267 (COM.TO) and Proteomics International Laboratories Limited (PIQ.AX), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
Proteomics International Laboratories Limited (PIQ.AX)0000N/A

Summary

Proteomics International Laboratories Limited (PIQ.AX) beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Proteomics International Laboratories Limited (PIQ.AX) (ASX:PIQ) and 17031 (CNSX:MYM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings and valuation.

Earnings and Valuation

This table compares Proteomics International Laboratories Limited (PIQ.AX) and 17031's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Proteomics International Laboratories Limited (PIQ.AX)$2.73 million0.00C$-2,098,120.00A($0.02)N/A
17031N/AN/AN/AN/AN/A

17031 has lower revenue, but higher earnings than Proteomics International Laboratories Limited (PIQ.AX).

Profitability

This table compares Proteomics International Laboratories Limited (PIQ.AX) and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Proteomics International Laboratories Limited (PIQ.AX)N/AN/AN/A
17031N/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and target prices for Proteomics International Laboratories Limited (PIQ.AX) and 17031, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Proteomics International Laboratories Limited (PIQ.AX)0000N/A
170310000N/A

Summary

Proteomics International Laboratories Limited (PIQ.AX) beats 17031 on 1 of the 1 factors compared between the two stocks.


Proteomics International Laboratories Limited (PIQ.AX) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
4BB
4basebio UK Societas
0.3N/AN/A£0.00N/A0.00Insider Buying
News Coverage
Gap Down
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
Abzena plc (ABZA.L) logo
ABZA
Abzena plc (ABZA.L)
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.25 million0.00High Trading Volume
News Coverage
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$3.83 million0.00High Trading Volume
News Coverage
Gap Up
ADTX
ADiTx Therapeutics
1.0$3.03flat$0.00N/A0.00
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
AGNPF
Algernon Pharmaceuticals
0.0$0.28flat$0.00N/A0.00Gap Down
LBTSF
Almirall
0.5$12.40flat$0.00N/A0.00
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
CBDC
Apotheca Biosciences
0.4$0.02flat$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.00flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
CDMOP
Avid Bioservices
0.3$29.60flat$0.00N/A0.00
AXIM
AXIM Biotechnologies
0.4$0.65flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.88flat$0.00N/A0.00
BGT
Bio-Gene Technology
0.5N/AN/A$0.00$82,795.000.00High Trading Volume
Gap Up
BNO
Bionomics Limited (BNO.AX)
0.5N/AN/A$0.00$3.19 million0.00High Trading Volume
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.32 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$7.56 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$240,243.000.00High Trading Volume
Gap Up
BTC
BTC Health Limited (BTC.AX)
0.5N/AN/A$0.00$131,934.000.00High Trading Volume
News Coverage
Gap Up
CNBX
Cannabics Pharmaceuticals
0.4$0.43flat$0.00N/A0.00News Coverage
Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid Limited (CDY.AX)
0.8N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
CBBT
Cerebain Biotech
0.0$0.14flat$0.00N/A0.00
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$16.95flat$0.00N/A0.00
CUV
Clinuvel Pharmaceuticals
0.6N/AN/A$0.00$32.57 million0.00High Trading Volume
Gap Up
CELZ
Creative Medical Technology
0.5$0.05flat$0.00N/A0.00Gap Down
CSL Limited (CSL.AX) logo
CSL
CSL Limited (CSL.AX)
0.8N/AN/A$0.00$9.98 billion0.00Dividend Cut
High Trading Volume
Gap Up
CLXPF
Cybin
1.0$1.27flat$0.00N/A0.00
CYP
Cynata Therapeutics
0.9N/AN/A$0.00$7.01 million0.00High Trading Volume
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00News Coverage
ENZC
Enzolytics
0.0$0.60flat$0.00N/A0.00
This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.